Germantown, MD · Founded 2019 · Privately Held (backing)
Developer of a virus-inspired therapeutic delivery platform designed to leverage the natural geometric structure of viruses for targeted payload transport. VerImmune is based in Germantown, MD and was founded in 2019. It was valued at $30 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $10 million across 2 recorded rounds; the latest was a $4.5 million seed round in Aug 2024.
PMV mark · valuation
$30.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$10.0M
Last round
Seed Round
Aug 2024
Team — not yet on record
No current team members for VerImmune are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of VerImmune with a free account
·The complete investor list: 12 names
·Watch VerImmune: the Monday email on marks, rounds and moves
